Seed · Biotech
Efferon raises €2.5M seed round
Efferon raised €2.5 million in seed financing announced in May.
The company develops hemoadsorption devices for sepsis and septic shock.
Funding history
Seed · This round€2.5M
Similar rounds
All Biotech rounds →Guoke Brain-Computer
Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.
UndisclosedSeed · Oct 23, 2026
Star Therapeutics
Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.
$200MPrivate financing · Oct 23, 2026
Pathos AI
Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.
$237MSeries E · Oct 23, 2026
Knowledge Work
Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.
¥4.8BSeries C debt second close · Oct 23, 2026